自组装的树枝状分子纳米药物配方,可降低与hERG相关的毒性,并增强治疗疗效
Xi Liu1,2, Dinesh Dhumal1, Patricia Santofimia-Castaño2
1Aix Marseille University, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille (CINaM), UMR 7325, Equipe Labellisée Ligue Contre le Cancer, 13288 Marseille, France.
Science advances
|June 25, 2025
概括
使用树脂分子纳米系统的纳米技术通过降低人类以太-a-go-go相关基因 (hERG) 通道结合,显著降低了药物诱导的心脏毒性. 这种方法提高了药物的有效性和安全性,为药物开发提供了新的前景.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 心脏毒性,特别是与hERG通道相关的毒性,是药物失效的主要原因.
- 减少hERG结合对于开发更安全的治疗方法至关重要.
- 目前在药物输送中的纳米技术应用仅限于对hERG相关心脏毒性的关注.
研究的目的:
- 调查自组装树突分子纳米系统降低hERG结合和相关心脏毒性的潜力.
- 评估具有高hERG亲和度的纳米配方药物的疗效和安全性.
主要方法:
- 开发用于药物封装的自组装树枝状分子纳米系统.
- 在 dendrimer 纳米系统内制备克洛洛昆,多克索鲁比和ZZW115.
- 在体外和动物模型中评估hERG结合亲和力和心脏毒性.
主要成果:
- 丹德里默纳米配方显示,hERG结合亲和力减少了三到八倍.
- 在体内研究表明,在用纳米药物治疗的动物模型中,心脏毒性已被废除.
- 纳米配方表现出延长的循环和在疾病部位增强的积累,改善治疗结果.
结论:
- 自组装的树突分子纳米系统有效地减少了hERG结合和心脏毒性.
- 这种纳米技术方法提高了药物的疗效和安全性.
- 基于丹德里默的纳米药物为缓解药物诱导的心脏毒性和改善治疗开发提供了一个有希望的策略.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


